Tumor blood flow modifying effect of electrochemotherapy with bleomycin.

BACKGROUND Electrochemotherapy combines administration of the chemotherapeutic drug, followed by application of electric pulses in order to increase drug delivery into the cells. The aim of this study was to determine the tumor blood flow modifying effect of electrochemotherapy with bleomycin and correlate it with its antitumor effectiveness and extent of tumor necrosis. MATERIALS AND METHODS Electrochemotherapy of SA-1 subcutaneous tumors in A/J mice was performed by application of electric pulses to the tumors, following administration of bleomycin, and antitumor effectiveness determined by tumor growth delay and tumor cures as well as extent of tumor necrosis. Tumor blood modifying effect of therapy was evaluated by Patent blue staining technique and 86RbCl extraction technique. RESULTS A good correlation of the two methods evaluating tumor blood flow, Patent blue staining and the established 86RbCl extraction technique was found (r = 0.944). Electrochemotherapy resulted in complete and permanent shut down of tumor blood flow within 12 hours, which lasted for at least 5 days. The results on tumor blood flow reduction correlated well with the good antitumor effectiveness of electrochemotherapy and with the extent of the necrosis in the tumors. CONCLUSIONS The results indicate that Patent blue staining technique is a simple and reliable method for estimation of tumor blood flow and that antitumor effectiveness of electrochemotherapy with bleomycin could be partly attributed to its tumor blood modifying and anti-vascular effect.

[1]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  L. Mir,et al.  Tumor treatment by direct electric current Tumor perfusion changes , 1997 .

[3]  D. Miklavčič,et al.  Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients , 1995 .

[4]  D. Miklavcic,et al.  Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. , 1998, British Journal of Cancer.

[5]  L. Mir,et al.  Cell electropermeabilization: a new tool for biochemical and pharmacological studies. , 1993, Biochimica et biophysica acta.

[6]  D. Miklavčič,et al.  Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content , 1998, Anti-cancer drugs.

[7]  M J Jaroszeski,et al.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy , 1996, Cancer.

[8]  M. Jaroszeski,et al.  Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy , 1997, Melanoma research.

[9]  L. Mir,et al.  Antitumor electrochemotherapy: New advances in the clinical protocol , 1996, Cancer.

[10]  T. Baère,et al.  ANTITUMOR ELECTROCHEMOTHERAPY: NEW AD-VANCES IN CLINICAL PROTOCOL , 1996 .

[11]  D Miklavcic,et al.  The importance of electric field distribution for effective in vivo electroporation of tissues. , 1998, Biophysical journal.

[12]  L. Mir,et al.  POTENTIATION OF ANTITUMOR EFFECTS OF BLEOMYCIN BY LOCAL ELECTRIC PULSES , 1991 .

[13]  G M Tozer,et al.  Modification of tumor blood flow: current status and future directions. , 1998, Seminars in radiation oncology.

[14]  M Cemazar,et al.  Tumour blood flow changes induced by application of electric pulses. , 1999, European journal of cancer.

[15]  B. Hirt.  [Anticancer research]. , 1981, Revue medicale de la Suisse romande.

[16]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[17]  J. Denekamp,et al.  Vascular occlusion and tumour cell death. , 1983, European journal of cancer & clinical oncology.

[18]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. , 1998, European journal of cancer.

[19]  E. Neumann,et al.  Digression on membrane electroporation and electroporative delivery of drugs and genes. , 1998 .

[20]  D Miklavcic,et al.  Calculation of the electrical parameters in electrochemotherapy of solid tumours in mice , 1998, Comput. Biol. Medicine.

[21]  W. Panje,et al.  Electroporation Therapy of Head and Neck Cancer , 1998, Annals of Otology, Rhinology and Laryngology.

[22]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.

[23]  Franci Demsar,et al.  CONTRAST ENHANCED MRI ASSESSMENT OF TUMOR BLOOD VOLUME AFTER APPLICATION OF ELECTRIC PULSES , 1998 .

[24]  J. Denekamp,et al.  Site dependent response of tumours to combined heat and radiation. , 1982, British Journal of Radiology.

[25]  Damijan Miklavčič,et al.  Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy , 1995 .

[26]  D. Miklavčič,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0222 , 2022 .

[27]  Damijan Miklavčič,et al.  Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice , 1996 .

[28]  L. Sapirstein,et al.  Regional blood flow by fractional distribution of indicators. , 1958, The American journal of physiology.

[29]  L. Mir,et al.  Systemic Antitumor Effects of Electrochemotherapy Combined with Histoincompatible Cells Secreting Interleukin‐2 , 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[30]  L. Mir,et al.  Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice , 1997 .